1.
Nazha A, Romo CG, Kantarjian H, Cortes J. The clinical impact of ponatinib on the risk of bleeding in patients with chronic myeloid leukemia. Haematologica [Internet]. 2013Oct.3 [cited 2026Nov.22];98(10):e131-e131. Available from: https://haematologica.org/article/view/6821